Vitamin and Asthma Study
Primary Purpose
Asthma
Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Vitamin D
Sponsored by

About this trial
This is an interventional treatment trial for Asthma focused on measuring Asthma, Pulmonary Function Test, Vitamin D
Eligibility Criteria
Inclusion Criteria:
- History of asthma (under control)otherwise in good general health
Exclusion Criteria:
- Poorly controlled asthma
- Taking daily multivitamin or vitamin D supplementation
- Taking oral steroid medication
- History of bronchopulmonary dysplasia or chronic lung disease, extreme prematurity, congenital heart disease, significant renal dysfunction or primary kidney disease, endocrinologic abnormalities of calcium metabolism or parathyroid disorders
Sites / Locations
- Pediatrics Allergy Clinic at Georgia Health Sciences University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
2000 IU vitamin D Daily
400 IU Vitamin D pill
Arm Description
Outcomes
Primary Outcome Measures
Change in Pulmonary Function Test (PFT) after vitamin D supplementation
Change in Asthma Control Test (ACT) scores after vitamin D supplementation
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01447173
Brief Title
Vitamin and Asthma Study
Study Type
Interventional
2. Study Status
Record Verification Date
October 2012
Overall Recruitment Status
Completed
Study Start Date
December 2010 (undefined)
Primary Completion Date
September 2011 (Actual)
Study Completion Date
September 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Augusta University
4. Oversight
5. Study Description
Brief Summary
The study looks at how vitamin D supplement will improve the severity of asthma and lung function as well as biomarkers in asthmatic children.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
Keywords
Asthma, Pulmonary Function Test, Vitamin D
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
2000 IU vitamin D Daily
Arm Type
Experimental
Arm Title
400 IU Vitamin D pill
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
Vitamin D
Intervention Description
Vitamin D 2000 IU daily pill Vitamin D 400 IU daily pill
Primary Outcome Measure Information:
Title
Change in Pulmonary Function Test (PFT) after vitamin D supplementation
Time Frame
4 weeks
Title
Change in Asthma Control Test (ACT) scores after vitamin D supplementation
Time Frame
4-week
10. Eligibility
Sex
All
Minimum Age & Unit of Time
7 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
History of asthma (under control)otherwise in good general health
Exclusion Criteria:
Poorly controlled asthma
Taking daily multivitamin or vitamin D supplementation
Taking oral steroid medication
History of bronchopulmonary dysplasia or chronic lung disease, extreme prematurity, congenital heart disease, significant renal dysfunction or primary kidney disease, endocrinologic abnormalities of calcium metabolism or parathyroid disorders
Facility Information:
Facility Name
Pediatrics Allergy Clinic at Georgia Health Sciences University
City
Augusta
State/Province
Georgia
ZIP/Postal Code
30912
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Vitamin and Asthma Study
We'll reach out to this number within 24 hrs